Humoral and cellular immune responses to AAV2 and ocular inflammation in patients after intravitreal injection of rAAV2/2-ND4 (GS010), an investigational gene therapy for the treatment of ND4 LHON

被引：0
|
作者：
Bouquet, C. [1 ]
Galy, A. [1 ]
Uretsky, S. [1 ]
Fitoussi, S. [1 ]
Cancian, C. [1 ]
Vignal, C. [2 ]
Sahel, J. A. [2 ]
Genead, M. [1 ]
Thomasson, N. [1 ]
机构：
[1] GenSight Biol, Paris, France
[2] Ctr Hosp Natl Ophtalmol Quinze Vingts, Paris, France
来源：
HUMAN GENE THERAPY | 2017年 / 28卷 / 12期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P210
引用
收藏
页码：A74 / A74
页数：1
相关论文
共 29 条
  • [1] Intravitreal injection of rAAV2/2-ND4 in LHON: absence of correlation between ocular inflammation and humoral or cellular immune responses to AAV2
    Katz, Barrett
    Galy, Anne
    Fitoussi, Serge
    Clermont, Catherine Vignal
    Sahel, Jose A.
    Cancian, Catherine
    Thomasson, Nitza
    Bouquet, Celine
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [2] Relationship between immune response and ocular inflammation after intravitreal injection of rAAV2/2-ND4 (GS010) in Leber hereditary optic neuropathy (LHON) patients
    Clermont, C. Vignal
    Bouquet, C.
    Uretsky, S.
    Galy, A.
    Thomasson, N.
    Fitoussi, S.
    Combal, J. P.
    Sahel, J.
    ACTA OPHTHALMOLOGICA, 2016, 94
  • [3] From non-human primates to patients: relationship between ocular inflammation and immune responses following intravitreal injection of rAAV2/2-ND4 (GS010)
    Thomasson, N.
    Galy, A.
    Fitoussi, S.
    Uretski, S.
    Vignal, C.
    Sahel, J.
    Combal, J.
    Bouquet, C.
    HUMAN GENE THERAPY, 2016, 27 (11) : A120 - A121
  • [4] Intravitreal rAAV2/2-ND4 (GS010): A gene therapy for vision loss in Leber's Hereditary Optic Neuropathy (LHON) caused by the G11778A ND4 mitochondrial mutation
    Uretsky, Scott
    Vignal, Catherine
    Thomasson, Nitza
    Bouquet, Celine
    Galy, Anne
    Combal, Jean Philipppe
    Fitoussi, Serge
    Sahel, Jose-Alain
    NEUROLOGY, 2017, 88
  • [5] Humoral immune response against AAV2/2-ND4 vector (GS010) after intravitreal administration in non-human primates and patients with Leber Hereditary Optic Neuropathy (LHON)
    Bouquet, C.
    Galy, A.
    Fitoussy, S.
    Meunier, S.
    Uretsky, S.
    Combal, J. P.
    Thomasson, N.
    HUMAN GENE THERAPY, 2015, 26 (10) : A8 - A8
  • [6] Baseline Structural and Psychophysical Profiles of Subjects Enrolled in Phase 3 Trials with rAAV2/2-ND4, an Investigational Gene Therapy for ND4 LHON
    Sergott, Robert C.
    Bryan, Molly Scannell
    Blouin, Laure
    Katz, Barrett
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [7] Allotopic Gene Therapy for ND4 Leber Hereditary Optic Neuropathy with rAAV2/2-ND4 (GS010): From Pre-Clinical Development to Phase III
    Uretsky, Scott
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [8] Safety, local tolerability and biodistribution of GS010 (AAV2/2-ND4), a gene therapy medicinal product in development for Leber Hereditary Optic Neuropathy (LHON)
    Thomasson, Nitza
    Cwerman-Thibault, Helene
    Augustin, Sebastien
    Simonuti, Manuel
    Sahel, Jose-Alain
    Pruneau, Didier
    Montus, Marie
    Galy, Anne
    Corral-Debrinski, Marisol
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [9] Phase I/IIa Visual Acuity Outcomes 1.5-Years Post-Treatment with rAAV2/2-ND4, an Investigational Gene Therapy for ND4 LHON
    Uretsky, Scott
    Thomasson, Nitza
    Bouquet, Celine
    Galy, Anne
    Combal, Jean Philppe
    Fitoussi, Serge
    Sahel, Jose Alain
    Vignal, Catherine
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [10] One-year follow-up study results after Intravitreal rAAV2/2-ND4 (GS010) injection in patients with vision loss due to G11778A ND4 Leber Hereditary Optic Neuropathy
    Vignal, C.
    Uretsky, S.
    Thomasson, N.
    Bouquet, C.
    Galy, A.
    Combal, J. Ph
    Fitoussi, S.
    Sahel, J. A.
    HUMAN GENE THERAPY, 2016, 27 (11) : A26 - A26
123